Advances in the cardiovascular assessment of patients with chronic kidney disease

NDT Plus

Volumn 1, Issue 6, 2008, Pages 383-391

  McIntyre, Chris W ^a,b,c   John, Stephen G ^b   Jefferies, Helen J ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Chronic kidney disease; Imaging; Metabolic stress; Monitoring

Indexed keywords

ACETYLCHOLINE; ADVANCED GLYCATION END PRODUCT; AMMONIA N 13; CONTRAST MEDIUM; CYTOKINE; DIPYRIDAMOLE; DOBUTAMINE; ENDOTHELIN; GADOLINIUM; NITROPRUSSIDE SODIUM; OXYGEN 15; THALLIUM; TRANSCRIPTION FACTOR; WATER;

ARTERY COMPLIANCE; AUTOFLUORESCENCE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD FLOW VELOCITY; BLOOD PRESSURE MEASUREMENT; CAPILLARY FLOW; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; CORONARY RISK; DEVICE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIALYSIS; DIGITAL ARTERY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; GRAFT DYSFUNCTION; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE FILLING; HEART SCINTISCANNING; HEMODIALYSIS PATIENT; HEMODYNAMIC MONITORING; HUMAN; HYPERGLYCEMIA; HYPERTHERMIA; INTERMETHOD COMPARISON; ISCHEMIA; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LASER DOPPLER FLOWMETRY; MEDICAL INSTRUMENTATION; MEDICAL TECHNOLOGY; METABOLIC STRESS; MICROCIRCULATION; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT MONITORING; PHARMACOLOGICAL PROCEDURES; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; PULSE WAVE; REVIEW; SCREENING TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN; SKIN BIOPSY; STRESS ECHOCARDIOGRAPHY; TISSUE DOPPLER IMAGING; TISSUE VELOCITY IMAGING; TONOMETRY; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRAVIOLET RADIATION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 56749175750     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn146     Document Type: Review

References (94)

1. Sigrist M, Bungay P, Taal MW et al. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714
2. Shimizu G, Hirota Y, Kita Y et al. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991; 83: 1676-1684
3. Zoccali C, Benedetto FA, Mallamaci F et al. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 2004; 15: 1029-1037
4. Zoccali C, Benedetto FA, Tripepi G et al. Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study. J Am Soc Nephrol 2006; 17: 1460-1465
5. Picano E, Lattanzi F, Orlandini A et al. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 1991; 17: 666-669
6. Philipson JD, Carpenter BJ, Itzkoff J et al. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 1986; 81: 630-634
7. Marwick TH, Steinmuller DR, Underwood DA et al. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 1990; 49: 100-103
8. Fragasso G, Lu C, Dabrowski P et al. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol 1999; 34: 441-447
9. Herzog CA, Marwick TH, Pheley AM et al. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999; 33: 1080-1090
10. Douglas PS, Khandheria B, Stainback RF et al. ACCF/ASE/ACEP/AHA/ ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. Circulation 2008; 117: 1478-1497
11. Cortigiani L, Zanetti L, Bigi R et al. Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients. J Hypertens 2002; 20: 1423-1429
12. Cortigiani L, Desideri A, Gigli G et al. Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates. Int J Cardiol 2005; 103: 168-174
13. Henein MY, Gibson DG. Normal long axis function. Heart 1999; 81: 111-113
14. Haluska BA, Short L, Marwick TH. Relationship of ventricular longitudinal function to contractile reserve in patients with mitral regurgitation. Am Heart J 2003; 146: 183-188
15. Greenbaum RA, Ho SY, Gibson DG et al. Left ventricular fibre architecture in man. Br Heart J 1981; 45: 248-263
16. Fathi R, Isbel N, Haluska B et al. Correlates of subclinical left ventricular dysfunction in ESRD. Am J Kidney Dis 2003; 41: 1016-1025
17. Fijalkowski M, Koprowski A, Gruchala M et al. Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end-stage renal disease. J Am Soc Echocardiogr 2006; 19: 1359-1364
18. Oki T, Tabata T, Yamada H et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997; 79: 921-928
19. Gorcsan J III, Strum DP, Mandarino WA et al. Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiography. Comparison with sonomicrometry and pressure-volume relations. Circulation 1997; 95: 2423-2433
20. Notomi Y, Lysyansky P, Setser RM et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol 2005; 45: 2034-2041
21. Notomi Y, Setser RM, Shiota T et al. Assessment of left ventricular torsional deformation by Doppler tissue imaging: validation study with tagged magnetic resonance imaging. Circulation 2005; 111: 1141-1147
22. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149
23. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998; 339: 173-181
24. Selby NM, Burton JO, Chesterton LJ et al. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 2006; 1: 1216-1225
25. Burton JO, McIntyre CW. Haemodialysis induced recurrent cardiac injury: determinants and associated outcomes. Abstract SU-FC001. ASN, 2007.
26. Burton JO, Korsheed S, McIntyre CW. Haemodialysis induced acute cardiac injury is associated with increased rates of ventricular arrhythmias. Renal Failure 2008; 30: 701-709
27. Cademartiri F, Palumbo AA, Maffei E et al. Non-invasive imaging of coronary arteries with 64-slice CT and 1.5T MRI: challenging invasive techniques. Acta Biomed 2007; 78: 6-15
28. Philippe F. Invasive angiography, computed tomography or magnetic resonance imaging for coronary imaging and cardiovascular risk stratification? Regulatory and practical considerations. Ann Cardiol Angeiol (Paris) 2004; 53: 79-90
29. Stewart GA, Foster J, Cowan M et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 1999; 56: 2248-2253
30. Mark PB, Johnston N, Groenning BA et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006; 69: 1839-1845
31. Stewart GA, Mark PB, Johnston N et al. Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging 2004; 24: 387-393
32. McGregor E, Jardine AG, Murray LS et al. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 1998; 13: 1499-1505
33. Bradlow WM, Gatehouse PD, Hughes RL et al. Assessing normal pulse wave velocity in the proximal pulmonary arteries using transit time: a feasibility, repeatability, and observer reproducibility study by cardiovascular magnetic resonance. J Magn Reson Imaging 2007; 25: 974-981
34. Dutka DP, Camici PG. The contribution of positron emission tomography to the study of ischemic heart failure. Prog Cardiovasc Dis 2001; 43: 399-418
35. 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET. J Nucl Med 2005; 46: 2009-2013
36. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990; 15: 459-474
37. McIntyre CW, Burton JO, Selby NM et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 2008; 3: 19-26
38. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519-560
39. London GM, Guerin A. Influence of arterial pulse and reflective waves on systolic blood pressure and cardiac function. J Hypertens Suppl 1999; 17: S3-S6
40. Ferro CJ, Savage T, Pinder SJ et al. Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int 2002; 62: 166-171
41. La Rovere MT, Pinna GD, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol 2008; 13: 191-207
42. Robinson TG, Carr SJ. Cardiovascular autonomic dysfunction in uremia. Kidney Int 2002; 62: 1921-1932
43. Petretta M, Bonaduce D, Marciano F et al. Effect of 1 year of lisinopril treatment on cardiac autonomic control in hypertensive patients with left ventricular hypertrophy. Hypertension 1996; 27: 330-338
44. Chapleau MW, Cunningham JT, Sullivan MJ et al. Structural versus functional modulation of the arterial baroreflex. Hypertension 1995; 26: 341-347
45. Kardos A, Rudas L, Simon J et al. Effect of postural changes on arterial baroreflex sensitivity assessed by the spontaneous sequence method and Valsalva manoeuvre in healthy subjects. Clin Auton Res 1997; 7: 143-148
46. Kornet L, Hoeks AP, Janssen BJ et al. Neural activity of the cardiac baroreflex decreases with age in normotensive and hypertensive subjects. J Hypertens 2005; 23: 815-823
47. Maule S, Veglio M, Mecca F et al. Autonomic neuropathy and QT interval in hemodialysed patients. Clin Auton Res 2004; 14: 233-239
48. Rubinger D, Revis N, Pollak A et al. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant 2004; 19: 2053-2060
49. Lerma C, Infante O, Perez-Grovas H et al. Poincare plot indexes of heart rate variability capture dynamic adaptations after haemodialysis in chronic renal failure patients. Clin Physiol Funct Imaging 2003; 23: 72-80
50. Lindgren K, Hagelin E, Hansen N et al. Baroreceptor sensitivity is impaired in elderly subjects with metabolic syndrome and insulin resistance. J Hypertens 2006; 24: 143-150
51. De Ferrari GM, Sanzo A, Bertoletti A et al. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50: 2285-2290
52. Cavalcanti S, Severi S, Chiari L et al. Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond) 1997; 92: 351-359
53. Chan CT, Jain V, Picton P et al. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 2005; 68: 338-344
54. Bondia A, Tabernero JM, Macias JF et al. Autonomic nervous system in haemodialysis. Nephrol Dial Transplant 1988; 3: 174-180
55. Smith SM, Potter JF, Samani NJ et al. Are baroreflex events detected by invasive and non-invasive techniques coincident? Clin Physiol Funct Imaging 2008; 28: 262-269
56. Chesterton LJ, Sigrist MK, Bennett T et al. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 2005; 20: 1140-1147
57. Chesterton LJ, Bennett T, Taal MW et al. Baroreflex sensitivity (BRS) is important in blood pressure control during haemodialysis and enhanced by dual chambed paired haemofiltration (PHF). Nephrol Dial Transplant 2005; 20: 331
58. John SG, Selby NM, McIntyre CW. Effects of peritoneal dialysis fluid biocompatibility on baroreflex sensitivity. Kidney Int Suppl 2008; 108: S119-S124
59. Westerhof BE, Gisolf J, Stok WJ et al. Time-domain cross-correlation baroreflex sensitivity: performance on the EUROBAVAR data set. J Hypertens 2004; 22: 1371-1380
60. Laude D, Elghozi JL, Girard A et al. Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol 2004; 286: R226-R231
61. Dawson SL, Robinson TG, Youde JH et al. The reproducibility of cardiac baroreceptor activity assessed non-invasively by spectral sequence techniques. Clin Auton Res 1997; 7: 279-284
62. Johansson M, Gao SA, Friberg P et al. Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure. Am J Hypertens 2005; 18: 995-1000, discussion 1016
63. Johansson M, Gao SA, Friberg P et al. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J Hypertens 2007; 25: 163-168
64. Rossi M, Cupisti A, Morelli E et al. Laser Doppler flowmeter assessment of skin microcirculation in uremic patients on hemodialysis treatment. Nephron 1996; 73: 544-548
65. Cracowski JL, Minson CT, Salvat-Melis M et al. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 2006; 27: 503-508
66. Taylor JE, Belch JJ, Henderson IS et al. Peripheral microcirculatory blood flow in haemodialysis patients treated with erythropoietin. Int Angiol 1996; 15: 33-38
67. Sigrist MK, McIntyre CW. Vascular calcification is associated with impaired microcirculatory function in chronic haemodialysis patients. Nephron Clin Pract 2008; 108: c121-c126
68. Wei K, Kaul S. The coronary microcirculation in health and disease. Cardiol Clin 2004; 22: 221-231
69. Olivotto I, Cecchi F, Camici PG. Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences. Ital Heart J 2004; 5: 572-580
70. Ragosta M, Samady H, Isaacs RB et al. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 2004; 147: 1017-1023
71. Pannier B, Guerin AP, Marchais SJ et al. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 2000; 57: 1091-1099
72. Pignocchino P, Conte MR, Scarnato S et al. Study of cutaneous microcirculation using the laser-Doppler method in syndrome X. Cardiologia 1994; 39: 193-197
73. Economides PA, Caselli A, Zuo CS et al. Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism 2004; 53: 222-227
74. Kruger A, Stewart J, Sahityani R et al. Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney Int 2006; 70: 157-164
75. Stewart J, Kohen A, Brouder D et al. Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am J Physiol Heart Circ Physiol 2004; 287: H2687-H2696
76. Shoji T, Tsubakihara Y, Fujii M et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66: 1212-1220
77. Wesseling KH, Jansen JR, Settels JJ et al. Computation of aortic flow from pressure in humans using a nonlinear, three-element model. J Appl Physiol 1993; 74: 2566-2573
78. Boon D, van Montfrans GA, Koopman MG et al. Blood pressure response to uncomplicated hemodialysis: the importance of changes in stroke volume. Nephron Clin Pract 2004; 96: c82-c87
79. Selby NM, Fonseca S, Hulme L et al. Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin. Nephrol Dial Transplant 2005; 20: 1848-1853
80. Jansen JR, Schreuder JJ, Mulier JP et al. A comparison of cardiac output derived from the arterial pressure wave against thermodilution in cardiac surgery patients. Br J Anaesth 2001; 87: 212-222
81. Selby NM, Lambie SH, Camici PG et al. Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 2006; 47: 830-841
82. Engoren M, Barbee D. Comparison of cardiac output determined by bioimpedance, thermodilution, and the Fick method. Am J Crit Care 2005; 14: 40-45
83. Keren H, Burkhoff D, Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol 2007; 293: H583-H589
84. Squara P, Denjean D, Estagnasie P et al. Noninvasive cardiac output monitoring (NICOM): a clinical validation. Intensive Care Med 2007; 33: 1191-1194
85. Locatelli F, Canaud B, Eckardt KU et al. Oxidative stress in endstage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-1280
86. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9
87. Makita Z, Radoff S, Rayfield EJ et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325: 836-842
88. Baynes JW. From life to death - the struggle between chemistry and biology during aging: the Maillard reaction as an amplifier of genomic damage. Biogerontology 2000; 1: 235-246
89. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003; 21: 3-12
90. Hartog JW, de Vries AP, Lutgers HL et al. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci 2005; 1043: 299-307
91. Meerwaldt R, Graaff R, Oomen PH et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47: 1324-1330
92. Lutgers HL, Graaff R, Links TP et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006; 29: 2654-9
93. Hartog JW, Smit AJ, van Son WJ et al. Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction. Am J Kidney Dis 2004; 43: 966-975
94. Meerwaldt R, Hartog JW, Graaff R et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 3687-3693